sNN-0031
- Generic Name
- sNN-0031
A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2016-01-27
- Lead Sponsor
- Newron Sweden AB
- Target Recruit Count
- 5
- Registration Number
- NCT01829867
- Locations
- 🇸🇪
Karolinska University Hospital Huddinge, Stockholm, Sweden
🇸🇪Skåne University Hospital Lund, Lund, Sweden
A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2015-01-12
- Lead Sponsor
- Newron Sweden AB
- Target Recruit Count
- 12
- Registration Number
- NCT00866502
- Locations
- 🇸🇪
Lund University Hospital, Lund, Sweden
🇸🇪Karolinska University Hospital, Huddinge, Stockholm, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath